Okamoto Takeshi, Takagi Koichi, Fukuda Katsuyuki
Department of Gastroenterology, St. Luke's International Hospital, 9-1 Akashicho, Chuo-ku, Tokyo 104-8560, Japan.
Case Rep Oncol Med. 2020 Jun 24;2020:8826657. doi: 10.1155/2020/8826657. eCollection 2020.
A 64-year-old Japanese man with no significant medical history presented with epigastric discomfort of 2-weeks' duration. He was diagnosed with metastatic HER2-positive gastric cancer. Chemotherapy with capecitabine, oxaliplatin, and trastuzumab was initiated. During the eighth cycle, he suddenly complained of electric shock-like pain in both legs upon neck flexion, consistent with Lhermitte's sign. Oxaliplatin was discontinued, and Lhermitte's sign resolved after 3 months. Neurotoxicity is commonly observed in platinum-based chemotherapy, but Lhermitte's sign is rare. This is the first report of oxaliplatin-induced Lhermitte's sign in a gastric cancer patient.
一名64岁无重大病史的日本男性出现持续两周的上腹部不适。他被诊断为转移性HER2阳性胃癌。开始使用卡培他滨、奥沙利铂和曲妥珠单抗进行化疗。在第八个疗程中,他突然抱怨颈部屈曲时双腿出现电击样疼痛,符合莱尔米特征。奥沙利铂停药,3个月后莱尔米特征消失。神经毒性在铂类化疗中很常见,但莱尔米特征很少见。这是首例关于奥沙利铂诱发胃癌患者出现莱尔米特征的报告。